The FDA has approved the first blood test for Alzheimer's disease based on a blood test – from Fujirebio – in a step forward for early diagnosis.

Neurologist Dr. Leah Croll reports on the first ever blood test approved by the Food and Drug Administration, giving the test ...

The test measures two proteins that are linked to amyloid plaques in the brain, which are among the hallmarks of Alzheimer's.

The Food and Drug Administration has approved the first blood test for diagnosing Alzheimer's disease, the agency announced ...

Researchers at the Keck School of Medicine of USC have made a major breakthrough in the early detection of Alzheimer’s ...

U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...

Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...

The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...

FDA approves Lumipulse G, the first blood test that can help in the diagnosis of Alzheimer's disease. Read more here.

The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment ...

PHOENIX (AZFamily/AP) — The U.S. Food and Drug Administration has cleared the first blood test to help in the diagnosis of Alzheimer’s disease. The Alzheimer’s Association said on Friday the test ...

The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker ...